Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer.
暂无分享,去创建一个
Y. Yatabe | Y. Horio | Y. Sakao | T. Hida | H. Kuroda | Kosuke Tanaka | J. Shimizu | Y. Oya | T. Yoshida
暂无分享,去创建一个
Y. Yatabe | Y. Horio | Y. Sakao | T. Hida | H. Kuroda | Kosuke Tanaka | J. Shimizu | Y. Oya | T. Yoshida